By G HossainPosted on June 8, 2026Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs Incyte is acquiring Vega Therapeutics, a subsidiary of Star Therapeutics, for a bleeding disorder program that analysts say has “pipeline-in-a-product” potential. Incyte’s stars align as new CEO strikes $2B Vega takeover for blood disorder asset Post navigation Roche makes up to $3B blood cancer play with Nurix’s protein degraderFulcrum axes 85% of staff after walking away from lead asset